These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 10640399)

  • 1. Mannosamine inhibits aggrecanase-mediated changes in the physical properties and biochemical composition of articular cartilage.
    Patwari P; Kurz B; Sandy JD; Grodzinsky AJ
    Arch Biochem Biophys; 2000 Feb; 374(1):79-85. PubMed ID: 10640399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
    Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
    Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chondrocyte-mediated catabolism of aggrecan: evidence for a glycosylphosphatidylinositol-linked protein in the aggrecanase response to interleukin-1 or retinoic acid.
    Sandy JD; Thompson V; Verscharen C; Gamett D
    Arch Biochem Biophys; 1999 Jul; 367(2):258-64. PubMed ID: 10395742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium pentosan polysulfate inhibits the catabolism of aggrecan in articular cartilage explant cultures.
    Munteanu SE; Ilic MZ; Handley CJ
    Arthritis Rheum; 2000 Oct; 43(10):2211-8. PubMed ID: 11037880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ceramide on aggrecanase activity in rabbit articular cartilage.
    Sabatini M; Thomas M; Deschamps C; Lesur C; Rolland G; de Nanteuil G; Bonnet J
    Biochem Biophys Res Commun; 2001 May; 283(5):1105-10. PubMed ID: 11355886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
    Chockalingam PS; Zeng W; Morris EA; Flannery CR
    Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage.
    Ilic MZ; Martinac B; Handley CJ
    Osteoarthritis Cartilage; 2003 Aug; 11(8):613-22. PubMed ID: 12880584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble recombinant neprilysin induces aggrecanase-mediated cleavage of aggrecan in cartilage explant cultures.
    Chevrier A; Mort JS; Crine P; Hoemann CD; Buschmann MD
    Arch Biochem Biophys; 2001 Dec; 396(2):178-86. PubMed ID: 11747295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine-induced cartilage proteoglycan degradation is mediated by aggrecanase.
    Arner EC; Hughes CE; Decicco CP; Caterson B; Tortorella MD
    Osteoarthritis Cartilage; 1998 May; 6(3):214-28. PubMed ID: 9682788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures.
    Munteanu SE; Ilic MZ; Handley CJ
    Matrix Biol; 2002 Aug; 21(5):429-40. PubMed ID: 12225808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coincubation of bovine synovial or capsular tissue with cartilage generates a soluble "Aggrecanase" activity.
    Vankemmelbeke MN; Ilic MZ; Handley CJ; Knight CG; Buttle DJ
    Biochem Biophys Res Commun; 1999 Feb; 255(3):686-91. PubMed ID: 10049771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chondrocyte-mediated catabolism of aggrecan: aggrecanase-dependent cleavage induced by interleukin-1 or retinoic acid can be inhibited by glucosamine.
    Sandy JD; Gamett D; Thompson V; Verscharen C
    Biochem J; 1998 Oct; 335 ( Pt 1)(Pt 1):59-66. PubMed ID: 9742213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
    Tortorella MD; Malfait AM; Deccico C; Arner E
    Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of hyaluronan metabolism by interleukin-1alpha in human articular cartilage.
    Nishida Y; D'Souza AL; Thonar EJ; Knudson W
    Arthritis Rheum; 2000 Jun; 43(6):1315-26. PubMed ID: 10857790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term gene expression changes in cartilage explants stimulated with interleukin beta plus glucosamine and chondroitin sulfate.
    Chan PS; Caron JP; Orth MW
    J Rheumatol; 2006 Jul; 33(7):1329-40. PubMed ID: 16821268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A inhibition of aggrecanase-mediated proteoglycan catabolism in articular cartilage.
    Little CB; Hughes CE; Curtis CL; Jones SA; Caterson B; Flannery CR
    Arthritis Rheum; 2002 Jan; 46(1):124-9. PubMed ID: 11817583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catabolism of aggrecan by explant cultures of human articular cartilage in the presence of retinoic acid.
    Ilic MZ; Mok MT; Williamson OD; Campbell MA; Hughes CE; Handley CJ
    Arch Biochem Biophys; 1995 Sep; 322(1):22-30. PubMed ID: 7574678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of aggrecan in human knee cartilage and synovial fluid indicates that aggrecanase (ADAMTS) activity is responsible for the catabolic turnover and loss of whole aggrecan whereas other protease activity is required for C-terminal processing in vivo.
    Sandy JD; Verscharen C
    Biochem J; 2001 Sep; 358(Pt 3):615-26. PubMed ID: 11535123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.